Nucleoside and nucleobase analogs in cancer treatment: not only sapacitabine, but also gemcitabine

F. Muggia, I. Diaz, G.J. Peters

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)403-408
JournalExpert Opinion on Investigational Drugs
Volume21
Issue number4
DOIs
Publication statusPublished - 2012

Cite this

@article{1920961b4fdb40baa3374b82d6ce2da2,
title = "Nucleoside and nucleobase analogs in cancer treatment: not only sapacitabine, but also gemcitabine",
author = "F. Muggia and I. Diaz and G.J. Peters",
year = "2012",
doi = "10.1517/13543784.2012.666236",
language = "Undefined/Unknown",
volume = "21",
pages = "403--408",
journal = "Expert Opinion on Investigational Drugs",
issn = "1354-3784",
publisher = "Taylor and Francis Ltd.",
number = "4",

}

Nucleoside and nucleobase analogs in cancer treatment: not only sapacitabine, but also gemcitabine. / Muggia, F.; Diaz, I.; Peters, G.J.

In: Expert Opinion on Investigational Drugs, Vol. 21, No. 4, 2012, p. 403-408.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Nucleoside and nucleobase analogs in cancer treatment: not only sapacitabine, but also gemcitabine

AU - Muggia, F.

AU - Diaz, I.

AU - Peters, G.J.

PY - 2012

Y1 - 2012

U2 - 10.1517/13543784.2012.666236

DO - 10.1517/13543784.2012.666236

M3 - Article

VL - 21

SP - 403

EP - 408

JO - Expert Opinion on Investigational Drugs

JF - Expert Opinion on Investigational Drugs

SN - 1354-3784

IS - 4

ER -